2CJP
In-game article clicks load inline without leaving the challenge.
2CJP, also known as 4-(4-bromo-2,5-dimethoxyphenyl)-2,3,4,5-tetrahydro-1H-2-benzazepine, is a serotonin receptor modulator of the phenethylamine, 2C, and N-benzylphenethylamine families. It is a cyclized phenethylamine analogue of 25B-NBOMe in which the N-benzylethylamine side chain has been cyclized to form a tetrahydrobenzazepine ring. The drug shows affinity for the serotonin 5-HT2A and 5-HT2C receptors (Ki = 19–457nM and 227–3,240nM, respectively). 2CJP was first described in the scientific literature by Michael Robert Braden of the lab of David E. Nichols at Purdue University in 2007.
See also
- Substituted methoxyphenethylamine
- Cyclized phenethylamine
- 25-NB
- 2CBecca
- 2CLisaB
- 2C-B-3PIP-NBOMe
- 2C-B-3PIP-POMe